Novel benzothiazole based imidazole derivatives as new cytotoxic agents against glioma (C6) and liver (HepG2) cancer cell lines
| dc.authorid | 0000-0002-2289-7950 | |
| dc.authorid | 0000-0002-0841-1299 | |
| dc.contributor.author | Yurttaş, Leyla | |
| dc.contributor.author | Ertaş, Merve | |
| dc.contributor.author | Akalın Çiftçi, Gülşen | |
| dc.contributor.author | Temel, Halide Edip | |
| dc.contributor.author | Demirayak, Şeref | |
| dc.date.accessioned | 10.07.201910:49:13 | |
| dc.date.accessioned | 2019-07-10T19:36:15Z | |
| dc.date.available | 10.07.201910:49:14 | |
| dc.date.available | 2019-07-10T19:36:15Z | |
| dc.date.issued | 2017 | |
| dc.department | İstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü, Farmasötik Kimya Ana Bilim Dalı | |
| dc.description.abstract | In this work, some novel N-(6-substituted-benzothiazol-2-yl)-2-[[4,5-dimethyl-1-((p-tolyl/4-nitrophenyl)amino)-1H-imidazol-2-yl]thio]acetamide derivatives were synthesized and searched for their cytotoxic activities against C6 and HepG2 tumor cells. Among all compounds, the most active compound was determined as compound 7. It was calculated IC50 value about 15.67 µg/mL through C6 tumor cell lines and also compound 2, 4, 5, 6 were observed as good cytotoxic agents against HepG2 tumor cells. Findings about antiproliferative activity studies have encouraged the acquirement of new similar compounds in undergoing studies. | |
| dc.identifier.citation | Yurttaş, L., Ertaş, M., Akalın Çiftçi, G., Temel, H. E. ve Demirayak, Ş. (2017). Novel benzothiazole based imidazole derivatives as new cytotoxic agents against glioma (C6) and liver (HepG2) cancer cell lines. Acta Pharmaceutica Sciencia, 55(1), 39-47. https://dx.doi.org/10.23893/1307-2080.APS.0553 | |
| dc.identifier.doi | 10.23893/1307-2080.APS.0553 | |
| dc.identifier.endpage | 47 | |
| dc.identifier.issn | 1307-2080 | |
| dc.identifier.issue | 1 | |
| dc.identifier.scopusquality | Q4 | |
| dc.identifier.startpage | 39 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/1106 | |
| dc.identifier.uri | https://dx.doi.org/10.23893/1307-2080.APS.0553 | |
| dc.identifier.volume | 55 | |
| dc.indekslendigikaynak | Scopus | |
| dc.language.iso | en | |
| dc.publisher | University of Istanbul | |
| dc.relation.ispartof | Acta Pharmaceutica Sciencia | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Antiproliferative Activity | |
| dc.subject | Benzothiazole | |
| dc.subject | Cytotoxicity | |
| dc.subject | Imidazole | |
| dc.title | Novel benzothiazole based imidazole derivatives as new cytotoxic agents against glioma (C6) and liver (HepG2) cancer cell lines | |
| dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- ertas-merve(2017).pdf
- Boyut:
- 215.93 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text











